FDA-Approved vs Research Compounds Understanding the distinction between FDA-approved peptides and research-only compounds is essential for evaluating safety: Category Examples Evidence Base Regulation FDA-Approved Semaglutide (Ozempic), Teriparatide (Forteo), Tesamorelin (Egrifta) Phase I-III clinical trials, post-market surveillance Prescription required, manufactured under cGMP Previously Approved Sermorelin (Geref withdrawn 2008) Clinical trial data exists, but product no longer marketed Research use only (currently) Research Only BPC-157, TB-500, Ipamorelin, KPV Preclinical data (varying depth), no completed human trials Sold for laboratory research, not human consumption For the complete list of FDA-approved peptides and their indications, see our FDA Approved Peptides List 2026 guide
By obtaining a drivers license and using public roads, every driver has legally consented in advance to chemical testing if lawfully arrested on DUI suspicion
Our guide on how much bacteriostatic water to add to peptides clarifies the ratios for various vial sizes
B12 vs Lipotropic Injections: UK Clinical Evidence B12 and lipotropic injections are distinct treatments often confused in wellness marketing
Overall, costs for the population of patients in this study are about 18,000 a year